Volume 24, Issue 1 pp. 23-31

Antidepressants versus psychotherapy for bulimia nervosa: a systematic review

J. Bacaltchuk

J. Bacaltchuk

1 Department of Psychiatry, Federal University of São Paulo, Paulista School of Medicine (UNIFESP-EPM)

Search for more papers by this author
R. P. Trefiglio

R. P. Trefiglio

2 Department of Preventive Medicine, Federal University of Sao Paulo, Paulista School of Medicine (Unifesp-EPM)

Search for more papers by this author
I. R. de Oliveira

I. R. de Oliveira

3 Department of Psychiatry, Federal University of Bahia

Search for more papers by this author
M. S. Lima

M. S. Lima

4 Department of Psychiatry, Federal University of Pelotas, Brazil

Search for more papers by this author
J. J. Mari

J. J. Mari

1 Department of Psychiatry, Federal University of São Paulo, Paulista School of Medicine (UNIFESP-EPM)

Search for more papers by this author
First published: 24 April 2006
Citations: 18
Bacaltchuk J. Rua Casa do Ator, 764/102 04506-003, Sao Paulo, Brazil. E-mail: [email protected]

Summary

Objective: To assess the efficacy and acceptability of antidepressants compared to psychotherapy as single approaches for the treatment of bulimia nervosa.

Method: Dichotomous outcomes were analysed by calculating relative risks and continuous outcomes by calculating effect sizes. The number needed to treat (or harm) was calculated. Methodological quality of trials and heterogeneity in the results were evaluated.

Results:A meta-analysis including five randomized controlled trials showed a non-significant difference in short-term remission of bulimic symptoms favouring psychotherapy. Remission rates were 20% for antidepressants and 39% for psychotherapy (P=0·07). Dropout rates were higher(P=0·027) for antidepressants (40%) than for psychotherapy (18%). The number needed to harm (NNH) was 4.

Discussion: Psychotherapy was superior to antidepressants, but using a more conservative statistical approach this difference, although clinically relevant, was not significant. The number of trials might be insufficient to show the significance of a 20% absolute risk reduction in efficacy. Psychotherapy was a better accepted treatment.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.